ACAD
Acadia Pharmaceuticals Inc

13,090
Mkt Cap
$4.18B
Volume
243.00
52W High
$28.35
52W Low
$13.40
PE Ratio
15.91
ACAD Fundamentals
Price
$24.59
Prev Close
$24.73
Open
$25.04
50D MA
$25.81
Beta
0.95
Avg. Volume
1.26M
EPS (Annual)
$1.36
P/B
4.56
Rev/Employee
$1.46M
$2,348.74
Loading...
Loading...

About

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
654

Frequently Asked Questions

What is Market Cap of Acadia Pharmaceuticals Inc?
What is the 52-week high for Acadia Pharmaceuticals Inc?
What is the 52-week low for Acadia Pharmaceuticals Inc?
What is Acadia Pharmaceuticals Inc stock price today?
What was Acadia Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Acadia Pharmaceuticals Inc?
What is the Price-to-Book ratio of Acadia Pharmaceuticals Inc?
What is the 50-day moving average of Acadia Pharmaceuticals Inc?
How many employees does Acadia Pharmaceuticals Inc have?

Latest ACAD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.